期刊文献+

老年肺癌患者淋巴细胞亚群检测的临床意义 被引量:6

Clinical significance of T lymphocyte subsets in peripheral blood of elderly patients with lung cancer
下载PDF
导出
摘要 目的探讨应用流式细胞术检测老年肺癌患者外周血淋巴细胞亚群各项指标的变化,以及老年肺癌患者不同分期该指标变化的临床意义。方法采用流式细胞术检测184例老年肺癌、166例老年肺部良性疾病患者外周血CD3+、CD4+、CD8+、CD4+/CD8+、NK细胞抗原的各项免疫学指标,并观察其在不同TNM肿瘤分期的变化特点。结果老年肺癌患者与老年肺部良性疾病患者相比,淋巴细胞亚群CD3+、CD4+、CD4+/CD8+比值下降,CD8+升高,NK细胞百分比下降,差异有统计学意义(P<0.05),且随着TNM肿瘤分期增高,上述变化越显著。结论流式细胞仪检测淋巴细胞抗原可作为临床评估老年肺癌患者免疫状态的有效依据。 Objective To explone the clinical significance of the variation of T lymphocyte subsets in peripheral blood of elderly patients with lung cancer.Methods Lymphocyte subsets counted in peripheral blood of 184 elderly lung cancer patients and 166 elderly lung benign disease patients were compared by flow cytometry,including CD3+,CD4+,CD8^+,CD4+/CD8^+,NK,and observed their characteristics in different TNM stages.Results CD3+,CD4+,CD4+/CD8^+ratio of elderly patients with lung cancer was lower than elderly lung benign disease patients,CD8^+ratio was higher in elderly lung cancer patients and NK ratio was lower,there was statistics significance on the differences(P0.05),and with the higher TNM stages,the variation was significant.Conclusion Detecting lymphocyte antigens by flow cytometry of elderly lung cancer patients can provide an effective basis for evaluating the immune condition in clinical work.
出处 《中国实用医药》 2012年第8期20-21,共2页 China Practical Medicine
关键词 老年肺癌患者 流式细胞仪 淋巴细胞亚群 Elderly lung cancer patient Flow cytometry Lymphocyte subsets
  • 相关文献

参考文献8

二级参考文献24

共引文献69

同被引文献54

  • 1石建华,束永前.高龄因素对老年肺癌化疗疗效影响的临床分析[J].临床和实验医学杂志,2007,6(7):14-15. 被引量:10
  • 2AnnOncol,ESMO(2010版)小细胞肺癌诊断、治疗和随访的临床实践指南[J].2010,21,(suppl5):v120-v125. 被引量:1
  • 3何维,主编.肿瘤免疫[J].医学免疫学.第2版.北京:人民卫生出版社,2010.8:331-340. 被引量:1
  • 4张延军,李宇,王玉红,等.小细胞肺癌患者化疗前后T淋巴细胞亚群的动态观察[J].现代中西医结合杂,2009,18(27):3311-3312. 被引量:1
  • 5陈文萍.小细胞肺癌的治疗优化策略探讨[J].肺癌多学科综合诊治进展,2011,11:25-33. 被引量:1
  • 6Auperin A,Le Pechoux C,Rolland E,et al.Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer[J].J Clin Oncol,2010,28:2181-2190. 被引量:1
  • 7Rowell NP,O'rourke NP.Concurrent chemoradiotherapy in non-small cell lung cancer[J].Cochrane Database Syst Rev,2004,4:2140. 被引量:1
  • 8Parmar M K,Ledermann J A,Colombo N. Paclitaxel plusplatinum-based chemotherapy versus conventional platinum based chemotherapy in women with relapsed ovarian cancer:the ICON4/AGO-0VAR-2.2 trial[J].{H}LANCET,2003,(9375):2099-2106. 被引量:1
  • 9Tang P A,Tsao M S,Moore M J. A review of erlotinib and its clinical use[J].{H}EXPERT OPINION ON PHARMACOTHERAPY,2006,(02):177-193. 被引量:1
  • 10Shepherd F A,Rodrigues Pereim J,Ciuleanu T. Erlotinib in previously treated non-small cell lung cancer[J].{H}New England Journal of Medicine,2010,(02):123-132. 被引量:1

引证文献6

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部